PHGE Stock Analysis: Buy, Sell, or Hold?
PHGE - BiomX Inc.
$0.87
-0.01 (-0.82%)
βΌ
5d:
-43.99%
30d:
+15.76%
90d:
-86.22%
WAIT
LOW Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: May 21, 2026
0d
Get Alerted When PHGE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
3 traders called PHGE this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
βΈοΈ WAIT FOR STABILIZATION: PHGE is down 44.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
βΈοΈ WAIT FOR STABILIZATION: PHGE is down 44.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: PHGE is currently trading at $0.87, which is considered fair relative to its 30-day fair value range of $0.51 to $1.16.
Technical Outlook: Technically, PHGE is in a strong downtrend. Immediate support is located at $0.38, while resistance sits at $1.89.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $304.00 (+34915.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PHGE is in a strong downtrend. Immediate support is located at $0.38, while resistance sits at $1.89.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $304.00 (+34915.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$0.51 -
$1.16
Company Quality Score
53/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
69.5%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: Trading 34915.0% below Wall St target ($304.00)
- WARNING: Recommendation downgraded due to -44.0% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$0.51 -
$1.16
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$0.38
Resistance Level
$1.89
Current Trend
Strong Downtrend
Technical data as of
Jun 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.14
Wall Street Target
$304.00
(+34915.0%)
Share & Embed Analysis
Last updated: June 03, 2026 7:59 PM ET
Data refreshes hourly during market hours. Next update: 8:59 PM
Data refreshes hourly during market hours. Next update: 8:59 PM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PHGE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Reuven Yeganeh
SELL
530000 shares
2026-03-17
Reuven Yeganeh
SELL
450000 shares
2026-03-16
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend BiotechΒ Corp |
STRONG BUY
22 analysts |
$55 | 66 BUY |
|
REGN
Regeneron Pharmaceutical⦠|
STRONG BUY
25 analysts |
$833 | 58 HOLD |
|
VRTX
Vertex Pharmaceuticals I⦠|
BUY
34 analysts |
$548 | 53 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 55 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 53 HOLD |